Valerie has particular knowledge of the FCA, Anti-Kickback Statute (AKS), Stark Law, diagnosis coding guidance, and federal and state regulations governing pharmacy benefit managers and drug manufacturers. She has long represented healthcare clients before the U.S. Department of Justice (DOJ), the Centers for Medicare & Medicaid Services (CMS), and Office of the Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS).
She also has extensive experience in corporate governance litigation, representing a broad range of companies and their directors and officers in securities fraud, breach of duty, derivative, and books and records inspection litigation. In cases involving shareholder demands, Valerie has investigated and advised boards of directors. She has conducted numerous internal employment investigations related to adverse employment actions and whistleblower allegations and advised on separation agreements and potential litigation for breaches of non-compete, non-solicitation, and confidentiality provisions.
Valerie has litigated Administrative Procedure Act (APA) and Freedom of Information Act (FOIA) cases against regulatory bodies. She has represented financial institutions before the Securities and Exchange Commission (SEC), DOJ, and state attorneys general. Valerie has defended issuers and underwriters in shareholder securities class actions and derivative actions brought in U.S. federal and state courts. She also successfully represented a large public company in an Employee Retirement Income Security Act (ERISA) matter involving an alleged breach of a top-hat benefit plan.
Valerie also maintains an active and dynamic pro bono practice, including a trial victory for an elderly disabled client, reparations and pension payments for Holocaust survivors for work performed in ghettos, and asylum for at-risk individuals.